News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Regional equities slid as Casablanca, Copenhagen, Istanbul and Warsaw all closed lower on sector-led losses.
  • Options traders trimmed crude risk premia after a U.S.-Iran ceasefire, but implied tail risk still shows a roughly 15–20% chance of higher Brent.
  • I Squared Capital and Blackstone are in talks to bid for Ströer's core out-of-home advertising unit.
  • Bezos-backed Slate Auto raised $650 million to fund production of a low-priced pickup and prepare deliveries late this year.
  • J.P. Morgan and Morgan Stanley recommended buying the dip, citing resilient corporate earnings and more attractive valuations.
  • A second federal bellwether trial began in Charlotte over an alleged Uber driver sexual assault, testing thousands of consolidated lawsuits.

Latest Articles

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

Crinetics Pharmaceuticals has submitted a Marketing Authorization Application to Brazil's ANVISA for Palsonify (paltusotine), the first once-daily oral therapy approved in the US for acromegaly. The submission follows positive Phase 3 trial results demonstrating efficacy and tolerability and complements recent regulatory progress in Europe. This ma…

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Kyverna Therapeutics reported significant progress in its autoimmune CAR T therapy pipeline, particularly with miv-cel (KYV-101) showing positive clinical results in stiff person syndrome (SPS), generalized myasthenia gravis (gMG), and progressive multiple sclerosis. The company plans a Biologics License Application (BLA) submission for SPS in the …

Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock

Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock

Zenas BioPharma has commenced underwritten public offerings of convertible senior notes due 2032 and common stock. The company plans to use net proceeds to support the U.S. commercial launch of obexelimab, advance its clinical development pipeline including Phase 3 trials of orelabrutinib, and for general corporate purposes. The offerings are subje…

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million

Apogee Therapeutics, a Nasdaq-listed clinical-stage biotech company, successfully closed its underwritten public offering, raising approximately $403 million. The offering included 5,750,000 shares sold at $70 each and full exercise of underwriters' options. Proceeds will support the company’s development of novel biologics targeting inflammatory a…

SIGA Declares Special Cash Dividend of $0.60 Per Share

SIGA Declares Special Cash Dividend of $0.60 Per Share

SIGA Technologies declared a special cash dividend of $0.60 per share payable on April 23, 2026. This dividend demonstrates SIGA's strong financial position and commitment to rewarding shareholders while continuing its work in biodefense, especially smallpox preparedness amid geopolitical uncertainties.

Global Stocks Slide as Brent Hits $108 on Escalating Iran Conflict

Global Stocks Slide as Brent Hits $108 on Escalating Iran Conflict

Stock indexes tumbled and global bond markets sold off on March 26 as a near-month-long conflict in the Middle East rekindled fears of prolonged disruption to oil and gas flows. Brent crude spiked to $108.01 a barrel while safe-haven demand pushed the U.S. dollar higher and gold lower. Market participants reacted to statements from Iranian and U.S.…

Data Centers Asked to Trim Consumption as U.S. Grid Faces Peak Stress

Data Centers Asked to Trim Consumption as U.S. Grid Faces Peak Stress

As electricity demand strains U.S. grids, technology firms are being pressed to adopt flexibility measures that allow data centers to reduce load during peak periods. Utilities, grid operators and investors are testing ways to temporarily shift or trim server workloads, use backup generation, or relocate energy-intensive processing across sites. Th…

EU Accuses Pornhub, Stripchat, XNXX and XVideos of Allowing Underage Access, Cites Digital Services Act Breaches

EU Accuses Pornhub, Stripchat, XNXX and XVideos of Allowing Underage Access, Cites Digital Services Act Breaches

The European Commission has provisionally charged four major adult content platforms - Pornhub, Stripchat, XNXX and XVideos - with breaching the EU's Digital Services Act after a 10-month probe found shortcomings in measures to prevent children accessing pornographic material. Regulators faulted the platforms for relying on weak self-declaration an…

Oil Majors Poised to Pocket Billions as Iran Conflict Sends Prices Soaring

Oil Majors Poised to Pocket Billions as Iran Conflict Sends Prices Soaring

Since the Iran conflict began on February 28, global energy prices have climbed sharply, and the resulting pull of supply through the Strait of Hormuz has stopped roughly one-fifth of worldwide flows. Benchmark Brent averaged about $97 per barrel in March, up from $69 in February and $65 in January. That surge is expected to boost revenues and lift…

Buy on Pullback: Astera Labs Looks Ready for a Mid-Term Rebound

Buy on Pullback: Astera Labs Looks Ready for a Mid-Term Rebound

Astera Labs (ALAB) has pulled back from last year’s highs into a more constructive setup. Strong AI-driven demand for high-speed networking, expanding product roadmap for Scorpio X-Series switches, solid cash and FCF generation, and bullish technicals create a favorable risk/reward for a mid-term trade. Valuation is rich, but the company’s fundamen…

Banxico lowers policy rate to 6.75%, leaves door open for another cut

Banxico lowers policy rate to 6.75%, leaves door open for another cut

Mexico’s central bank reduced its benchmark interest rate by 25 basis points to 6.75%, moving from 7.00% and signaling it is considering an additional cut though offering no timetable. Banxico cited the exchange rate, subdued economic activity in early 2026, and the level of existing monetary restriction as determinants of the decision, while notin…

Pernod Ricard and Brown-Forman Hold Merger Talks, Sources Say

Pernod Ricard and Brown-Forman Hold Merger Talks, Sources Say

Pernod Ricard and Brown-Forman have engaged in discussions over a potential merger, according to a source familiar with the matter. The talks would combine a wide-ranging global spirits portfolio with the leading American whiskey business as the sector contends with multi-year sales weakness, tariff-driven pressures and changing consumer behavior. …

Alamos Gold Provides Notice of Completion of Annual Filings

Alamos Gold Provides Notice of Completion of Annual Filings

Alamos Gold Inc. has filed its annual information form and 2025 annual report including audited financial statements with both the U.S. SEC and Canadian securities authorities. These documents are accessible online and available to shareholders upon request. The company operates gold mines in Canada and Mexico and has several growth projects underw…

Kaltura Director Purchases 8,064 Shares in Modest Insider Buy

Kaltura Director Purchases 8,064 Shares in Modest Insider Buy

A Kaltura Inc. director, Dracon Gregory C., bought 8,064 shares on March 24, 2026, paying $1.235 per share for a $9,959 transaction, according to a Form 4 filing. The holdings now give the director direct ownership of 8,064 shares. The stock is trading above the purchase price at $1.36. Recent quarterly results showed a notable EPS beat and slightl…

Occidental Stock Climbs as Leadership Change Nears

Occidental Stock Climbs as Leadership Change Nears

Shares of Occidental Petroleum rose after reports indicated that long-serving CEO Vicki Hollub is preparing to retire later this year and that Chief Operating Officer Richard Jackson is expected to take over. The transition is described as likely to include an interim period during which Hollub may stay on as an adviser or be named CEO-designate wh…